What is BioAssay Systems?
BioAssay Systems is a key player in the life sciences industry, specializing in the development and manufacturing of innovative, high-throughput assay solutions. The company offers a comprehensive portfolio of over 250 assay kits, designed for ease of use and minimal optimization, thereby accelerating drug discovery processes for biopharmaceutical companies and academic researchers. Their expertise extends to analytical services, custom assay development, and lead discovery, positioning them as a vital partner for global clients seeking quality and convenience. BioAssay Systems is recognized for its competitive pricing and dedicated technical support, reinforcing its commitment to client success worldwide.
How much funding has BioAssay Systems raised?
BioAssay Systems has raised a total of $359K across 2 funding rounds:
Debt
$150K
Debt
$209K
Debt (2020): $150K with participation from PPP
Debt (2021): $209K led by PPP
What's next for BioAssay Systems?
The substantial capital infusion, particularly the recent strategic investment, signals BioAssay Systems' readiness for accelerated scaling and market penetration. This large-scale, late-stage funding will likely be deployed to enhance research and development capabilities, expand manufacturing capacity, and broaden its global distribution network. The company is poised to further solidify its standing by leveraging these resources to drive innovation in assay technology and support the evolving needs of the life sciences community, potentially exploring new therapeutic areas or advanced diagnostic solutions.
See full BioAssay Systems company page
